Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Colorcon
Medtronic
Teva
Julphar
Queensland Health
Fish and Richardson
Daiichi Sankyo
QuintilesIMS

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084305

« Back to Dashboard

NDA 084305 describes MYDRIACYL, which is a drug marketed by Alcon, Novartis Pharms Corp, and Sandoz Inc, and is included in three NDAs. It is available from two suppliers. Additional details are available on the MYDRIACYL profile page.

The generic ingredient in MYDRIACYL is tropicamide. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the tropicamide profile page.
Summary for 084305
Tradename:MYDRIACYL
Applicant:Sandoz Inc
Ingredient:tropicamide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 084305
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for 084305
Suppliers and Packaging for NDA: 084305
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MYDRIACYL tropicamide SOLUTION/DROPS;OPHTHALMIC 084305 ANDA Sandoz Inc. 61314-354 61314-354-01 1 BOTTLE, PLASTIC in 1 CARTON (61314-354-01) > 15 mL in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.5%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
Queensland Health
Dow
Merck
Cantor Fitzgerald
Fuji
Mallinckrodt
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot